Autolus Therapeutics (AUTL) Times Interest Earned (2018 - 2025)
Autolus Therapeutics (AUTL) posted quarterly Times Interest Earned of -$3.17 for Q4 2025, down 228.98% year-on-year from $2.46 in Q4 2024, and down 425.97% on a QoQ basis from -$0.6 in Q3 2025.
Autolus Therapeutics (AUTL) Times Interest Earned (2018 - 2025) Analysis & Trends
Autolus Therapeutics (AUTL) has reported Times Interest Earned for 8 consecutive years, with -$3.17 the latest figure, recorded in Q4 2025.
- Quarterly Times Interest Earned fell 228.98% year-over-year to -$3.17 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$21.04 (up 19.02% YoY) and the FY2025 annual result came in at -$1.09, up 29.07% from the prior year.
- Times Interest Earned fell to -$3.17 in Q4 2025 per AUTL's latest filing, from -$0.6 in the prior quarter.
- Over the last five years, Times Interest Earned for AUTL reached as high as $2.46 in Q4 2024 and fell as low as -$38.56 in Q1 2021.
- A 5-year average of -$9.36 and a median of -$6.07 in 2024 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2024 — Times Interest Earned surged 239.15% — and 2025, when it slumped 228.98%.
- Year by year, Times Interest Earned stood at -$20.9 in 2021, then surged by 83.88% to -$3.37 in 2022, then surged by 47.53% to -$1.77 in 2023, then soared by 239.15% to $2.46 in 2024, then sank by 228.98% to -$3.17 in 2025.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$3.17, -$0.6, and -$0.51 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Autolus Therapeutics | 404.53 Mn | 103.82 Mn | -1.04 Mn | -3.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.17 |
| Sep 30, 2025 | -0.60 |
| Jun 30, 2025 | -0.51 |
| Mar 31, 2025 | -0.59 |
| Dec 31, 2024 | 2.46 |
| Sep 30, 2024 | -6.35 |
| Jun 30, 2024 | -5.79 |
| Mar 31, 2024 | -2.01 |
| Dec 31, 2023 | -1.77 |
| Sep 30, 2023 | -8.56 |
| Jun 30, 2023 | -8.84 |
| Mar 31, 2023 | -7.98 |
| Dec 31, 2022 | -3.37 |
| Sep 30, 2022 | -20.19 |
| Jun 30, 2022 | -21.58 |
| Mar 31, 2022 | -20.22 |
| Dec 31, 2021 | -20.90 |
| Mar 31, 2021 | -38.56 |
| Dec 31, 2020 | 473.30 |
| Sep 30, 2020 | -427.08 |